These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8644030)

  • 1. [The clinical, hemodynamic and hormonal-metabolic effects of the calcium-antagonist treatment of middle-aged and elderly patients with IHD at the polyclinic stage of rehabilitation].
    Pimenov LT; Ezhov AV; Churshin AD; Dudarev MV
    Ter Arkh; 1996; 68(1):42-5. PubMed ID: 8644030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Response to metabolic therapy with amino acid complex in aged patients with ischemic heart disease].
    Zaslavskaia RM; Kelimberdieva ES; Teĭblium MM; Komissarova IA; Kalinina EV
    Klin Med (Mosk); 1999; 77(4):39-42. PubMed ID: 10356916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An evaluation of the efficacy of treating IHD patients with calcium antagonists].
    Mordovin VF; Triss SV; Fedorova NA; Chernov VI; Krylov A; Pavliukova EN; Karpov RS
    Ter Arkh; 1995; 67(6):5-8. PubMed ID: 7667781
    [No Abstract]   [Full Text] [Related]  

  • 4. [The hemodynamic status of patients with ischemic heart disease under long-term treatment with calcium antagonists].
    Bychko MV
    Lik Sprava; 1999; (3):62-5. PubMed ID: 10474938
    [No Abstract]   [Full Text] [Related]  

  • 5. [The comparative efficacy of verapamil, nifedipine and propranolol in patients with IHD and an enhanced risk of a fatal outcome].
    Mazur NA; Pavlova TS; Vasil'eva NN; Kul'ginskaia IV
    Ter Arkh; 1994; 66(8):26-30. PubMed ID: 7527161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calcium antagonist therapy of middle-aged and aged patients with angina pectoris during the outpatient stage of rehabilitation].
    Pimenov LT; Ezhov AV; Churshin AD
    Klin Med (Mosk); 1995; 73(5):69-71. PubMed ID: 8815289
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adalat effects on clinical course of coronary heart disease, peripheral circulation and myocardial perfusion in patients with stenosing coronary atherosclerosis].
    Garganeeva AA; Tepliakov AT; Chernov VI; Braslavskaia TG
    Ter Arkh; 1998; 70(9):61-3. PubMed ID: 9821229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
    Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
    Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of diltiazem on neurohumoral regulatory mechanisms in stenocardia patients].
    Kniaz'kova II; Belovol AN; Tsygankov AI
    Lik Sprava; 1998 Aug; (6):86-90. PubMed ID: 9844884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinico-hemodynamic effects of the antioxidant ceruloplasmin in IHD patients].
    Zakirova AN
    Ter Arkh; 1995; 67(4):33-5. PubMed ID: 7784970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinico-pharmacological study of the antianginal and anti-ischemic efficacy of a new drug form of diltiazem with delayed release].
    Belousov IuB; Upnitskiĭ AA; Sokolov AV; Tishchenkova NF; Karasev AV; Egorova NA
    Ter Arkh; 1997; 69(3):61-3. PubMed ID: 9229836
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of a compound preparation pumpan on exercise tolerance and clinical course of ischemic heart disease].
    Krasnitskiĭ VB; Aronov DM; Zhidko NI
    Ter Arkh; 2003; 75(8):17-21. PubMed ID: 14520844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diltiazem and verapamil therapy in patients with angina pectoris associated with arterial hypotension].
    Idrisova EM; Stepacheva TA; Borovkova NV; Chernov VI; Karpov RS; Vorob'eva EV; Poponina IuS
    Klin Med (Mosk); 2004; 82(2):42-6. PubMed ID: 15106511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficiency and safety of a long-lasting form of diltiazem in the treatment of hypertensive patients with ischemic heart disease].
    Svetyĭ LI; Pavlova LI; Mazerkina IA
    Klin Med (Mosk); 2002; 80(8):58-61. PubMed ID: 12360623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium metabolism and the diastolic rigidity status of the myocardium in patients with ischemic heart disease under the influence of calcium antagonist treatment].
    Lomakovs'kyĭ OM; Mkhytarian LS
    Fiziol Zh (1978); 1992; 38(1):22-6. PubMed ID: 1555721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The calcium antagonists diltiazem and nifedipine: a comparison of their efficacy in single and long-term use in patients with stable stenocardia of effort].
    Martsevich SIu; Kutishenko PP; Alimova EV; Slastnikova ID; Metelitsa VI
    Ter Arkh; 1998; 70(8):21-5. PubMed ID: 9770738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium antagonists in ischemic heart disease].
    Guize L
    J Mal Vasc; 1997 Oct; 22(4):222-8. PubMed ID: 9411006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Views on the use of calcium channel blockers in the treatment of heart ischemia and hypertension].
    Halawa B
    Pol Merkur Lekarski; 1998 Sep; 5(27):107-10. PubMed ID: 10101470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.